Conference reports

Six-week ledipasvir/sofosbuvir in HIV positive patients with acute HCV

1 June 2016. Related: Conference reports, Hepatitis coinfection.

6th International Workshop on HIV & Women, 20-21 February 2016, Boston

1 June 2016. Related: Conference reports.

Doravirine can be co-administered with oral contraceptives

1 June 2016. Related: Conference reports, Women's health.

No increased risk of birth defects with darunavir: findings from the Antiretroviral Pregnancy Registry

1 June 2016. Related: Conference reports, Pregnancy.

23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016), 22-25 February 2016, Boston

22 March 2016. Related: Conference reports.

Dual long-acting injections of cabotegravir plus rilpivirine: 32-week results from LATTE-2 study

22 March 2016. Related: Conference reports, Antiretrovirals.

New NRTI MK-8591 (EFdA): weekly oral dosing and once-yearly slow-release dosing has potential for HIV treatment and PrEP

22 March 2016. Related: Conference reports, Antiretrovirals.

Similar viral load reductions at week 4 when dolutegravir is used with 2- or 3-drug initial ART

22 March 2016. Related: Conference reports, Antiretrovirals.

48-week results for NNRTI doravirine compared to efavirenz

22 March 2016. Related: Conference reports, Antiretrovirals.

Dramatic increase in use of oral TDF/FTC for PrEP in the US – plus a few cautions

22 March 2016. Related: Conference reports, HIV prevention and transmission.

Future oral and long-acting formulations for PrEP: pills, films, gels, injections and depots

22 March 2016. Related: Conference reports, HIV prevention and transmission.

First data on TAF as PrEP to prevent HIV infection

22 March 2016. Related: Conference reports, HIV prevention and transmission.

Long-acting cabotegravir as PrEP protects macaques against IV exposure but will need two-monthly injections

22 March 2016. Related: Conference reports, HIV prevention and transmission.

Role for maraviroc as HIV PrEP likely to need dual combinations

22 March 2016. Related: Conference reports, HIV prevention and transmission.

Dapivirine PrEP vaginal ring shows only limited PrEP protection against HIV in African women

22 March 2016. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.

Early data from dolutegravir use during pregnancy

22 March 2016. Related: Conference reports, Pregnancy.

Dolutegravir: 48 week results in children age 6 to 12 years old

22 March 2016. Related: Conference reports, Paediatric care.

New antiretrovirals could mean savings up to US $3 billion by 2025

22 March 2016. Related: Conference reports, Treatment access.

Countries with lower HIV prevalence have lower ART coverage

22 March 2016. Related: Conference reports, Antiretrovirals, Treatment access.

Nigerian herbal medicines widely used by HIV positive people can contain antiretrovirals

22 March 2016. Related: Conference reports, Antiretrovirals.

Cure research news from CROI 2016

22 March 2016. Related: Conference reports, Cure-related research.

46th World Conference on Lung Health of the International Union Against TB and Lung Disease

1 February 2016. Related: Conference reports.

Promising first results with a 9-month regimen for multidrug resistant tuberculosis in French-speaking African countries

1 February 2016. Related: Conference reports, TB coinfection.

Pharmacokinetics of old and new TB drugs for children

1 February 2016. Related: Conference reports, PK and drug interactions, TB coinfection.

The REALITY trial: cotrimoxazole/isoniazid/pyridoxine tablets are bioequivalent to individual products and are acceptable to participants

1 February 2016. Related: Conference reports, TB coinfection.

BHIVA Autumn Conference 2015, 12-13 November 2015, London

1 February 2016. Related: Conference reports.

Selected webcasts from BHIVA Autumn conference 2015

1 February 2016. Related: Conference reports, On the web.

15th European AIDS Conference (EACS), 21-24 October 2015, Barcelona

1 December 2015. Related: Conference reports.

Remarkable results with dolutegravir monotherapy

1 December 2015. Related: Conference reports, Antiretrovirals, Vaccines and microbicides.

First-line ART with dolutegravir plus 3TC: 24-week early results

1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies.

New European HIV guidelines (October 2015): universal ART, first-line integrase and PrEP

1 December 2015. Related: Conference reports, Guidelines.

Impact of early ART on lung function: results on ART and COPD from START substudy

1 December 2015. Related: Conference reports, Coinfections and complications.

No difference in neuropsychological test results between early and delayed ART in START substudy

1 December 2015. Related: Conference reports, Side effects, Coinfections and complications.

Immediate ART in START linked to greater bone loss over three years

1 December 2015. Related: Conference reports, Side effects.

Price of MDR TB drugs could be greatly reduced with competitive generic manufacture

1 December 2015. Related: Conference reports, Treatment access, TB coinfection.

Potential for generic prices for 12 weeks sofosbuvir treatment to drop below US $300 and daclatasvir to US $23

1 December 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.

Achieving viral suppression with HIV multi-drug resistance: peg-interferon and valaciclovir as part of rescue therapy

1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, Drug resistance.

French cohort of HIV transgender women highlights issues relating to HIV management

1 December 2015. Related: Conference reports.

7th International Workshop on HIV Paediatrics, 17-18 July, Vancouver, Canada

1 December 2015. Related: Conference reports.

Substituting lopinavir/ritonavir with efavirenz in children on stable ART

1 December 2015. Related: Conference reports, Antiretrovirals, Paediatric care.

The effects of systemic efavirenz exposure, sex and age on risk of viral non-suppression

1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions.

Pharmacokinetics of lopinavir/ritonavir super-boosting in infants and young children co-infected with HIV and TB

1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.

55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17-21 September 2015, San Diego

1 October 2015. Related: Conference reports.

No transmission of integrase-resistant HIV seen in California cohort

1 October 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, Drug resistance.

Doubled hypogonadism rate in middle-aged men with HIV: fat is a factor

1 October 2015. Related: Conference reports, Antiretrovirals, Side effects.

Protection against flu but not HBV in vaccinated perinatally HIV-infected children

1 October 2015. Related: Conference reports, Paediatric care, Hepatitis coinfection.

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19-22 July 2015, Vancouver, Canada

1 October 2015. Related: Conference reports.

The PrEP experience: IAS 2015 and beyond

1 October 2015. Related: Conference reports, HIV prevention and transmission.

Raltegravir for neonates will require a complicated dosing regimen

1 October 2015. Related: Conference reports, Pregnancy, Paediatric care.

News and notes on HIV cure research from IAS 2015

1 October 2015. Related: Conference reports, Cure-related research.

16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, 26-28 May 2015, Washington DC

1 October 2015. Related: Conference reports.

Reducing efavirenz dose is unlikely to overcome interaction with levonorgestrel

1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.

Doravirine and cabotegravir do not affect the pharmacokinetics of oral contraceptives

1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, PK and drug interactions.

Pharmacokinetics of four antiretrovirals in pregnancy: data from the PANNA network

1 October 2015. Related: Conference reports, Pregnancy, PK and drug interactions.

Dolutegravir placental transfer moderate in ex vivo model

1 October 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.

Paediatric dosing of DRV/r

1 October 2015. Related: Conference reports, Paediatric care, PK and drug interactions.

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19 – 22 July 2015, Vancouver, Canada

1 August 2015. Related: Conference reports.

Tribute to Bob Munk: long-time HIV positive US treatment activist and educator

1 August 2015. Related: In memory, Conference reports.

Four reasons IAS 2015 will be a milestone HIV conference: a personal view

1 August 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, HIV prevention and transmission.

Starting HIV treatment at high CD4 counts protects against both AIDS and non-AIDS events: overall and in subgroup analyses of START study

1 August 2015. Related: Conference reports, Antiretrovirals, Treatment strategies.

The option for same day antiretroviral therapy on diagnosis: the future model for HIV care

1 August 2015. Related: Conference reports, Treatment strategies, Treatment access, Treatment advocacy, Other news.

Post navigation